HCW Biologics
HCWB
NASDAQ
IPO2021
about HCWB
HCW Biologics specializes in developing cell-based therapies for tissue repair and regenerative medicine solutions to address various medical needs.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $5.49 | $6.11 | $4.74 | $12.03M | 20.11M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$6.79 | n/a | 1478.44 | -52886.67% | -29430.99% | 0% |